About four months ago, my wife was diagnosed with
VasculitisNecrotizing vasculitis of the
CentralCentral sleep apnea
Central-vite Nervous System. She is taking
PrednisonePrednisone
Prednisone anhydrous and
Imuran. A recent MRI shows that the
vasculitisNecrotizing vasculitis has diminished significantly, and she feels better overall --
recognizingRecognizing medical emergencies that there are bad days as well as good. However, my wife's eyesight has been declining steadily over these months. Recently, the eyesight became much worse -- with pressure, cloudiness and a further reduced visual field, and she often cannot see well enough to read. (It's like looking through crumbled cellophane.) She does her best to keep active and positive, and answers to two questions would help us greatly.
What are the benchmarks for PACNS? We need some perspective on what we might expect over time, even in general terms. Milestones will help us better recognize progress and accept setbacks. How does it go with PACNS -- slow and steady progress or decline, or what? In general, after how many months might we expect what kinds of changes?
Is it expected that eyesight would be affected by PACNS? My wife's vision is much, much worse now than at any other time. Has the PACNS affected the part of the brain that handles vision? Can the medications play a part this decline? Could the vision problem be unrelated? What should we, and her doctors, be doing right now to reduce or eliminate the likelihood of permanent vision damage?
We will appreciate any information you might provide.
The diagnosis of PACNS (Primary Angiitis of the Central Nervous System) was confirmed by Dr. Calabrese of the Cleveland Clinic after a visit there. We'd appreciate your comments about the milestones or benchmarks we might expect, understanding that those comments, of necessity, will be general.
My wife has seen a neuro-opthamologist group. They haven't identified a cause of the vision problems and are somewhat at a loss as to how to proceed. We are hoping you can give us some guidance on possible next steps.